Cognetivity Neurosciences Ltd. (1UB)

Overview

Cognetivity Neurosciences Ltd. is recognized as a technology company with a specialized focus on cognitive assessment platforms. Originally operating under the name Utor Capital Corp., the company underwent a rebranding to its current identity in December 2017. Since its inception in 2015, Cognetivity Neurosciences has dedicated itself to advancing cognitive diagnostics and monitoring. It is strategically headquartered in Vancouver, Canada, positioning itself in a region known for its robust tech and medical research sectors. The company's mission revolves around the early diagnosis of dementia through its innovative technology, aiming to make significant contributions to both medical fields and consumer wellness.

Products and Services

• Integrated Cognitive Assessment (ICA)

  This cognitive testing platform stands at the forefront of Cognetivity Neurosciences' offerings, designed for application across medical, commercial, and consumer settings. The ICA tool offers a promising solution for the early diagnosis of dementia, leveraging cutting-edge technology to detect subtle cognitive changes. Its adaptability allows it to be a valuable tool for healthcare professionals in monitoring brain health, as well as for individuals keen on tracking their cognitive function over time.

• OptiMind Wellness App

  Complementing its suite of cognitive assessment technologies, the OptiMind Wellness App represents Cognetivity's venture into consumer wellness solutions. This app is developed with the aim of supporting general cognitive wellness, providing users with actionable insights and data on their cognitive performance. It signifies the company's commitment to broader health and wellness, aligning with its core mission of enhancing cognitive health awareness and management.